Since this molecular model of selective regulation of GR target genes by G9a, GLP and HP1γ is operational in cell lines representing two very different cell types—A549 lung adenocarcinoma cells and Nalm6 B-ALL cells—it appears likely that it will be operational in many if not all cell types. This evidence concerns the gene EHMT1 and acute lymphoblastic leukemia.